Inari Medical (NARI), one of the leading biotechnology companies, manufactures a product that helps prevent deep vein thrombosis and pulmonary embolisms. It is estimated that the potential market is worth more than $ 4 billion for the Inari Medical’s products.
ClotTriever and FlowTriever are two of Inari Medical’s innovative products that treat deep vein thrombosis and pulmonary embolism.
These instruments make it possible to remove blood clots without requiring medications and long in-patient stays, and effective removals of substantial volumes. Also, hospitals can use disposable tools without spending large amounts of money on additional equipment.
Although deep vein thrombosis causes very little death, it can impair motor function and performance. On the other hand, pulmonary thromboembolism is the third leading cause of death from cardiovascular diseases and the number one cause of preventable deaths in hospitals.
The commercial potential of Inari Medical’s developments is excellent. Presently, the therapy is used by a mere 5 % of patients targeted. Overall, the NARI stock estimates its target market at $ 3.8 billion.
Despite some procedures postponed due to the pandemic, Inari Medical’s (NARI) revenues grew 144 % in the fourth quarter of fiscal 2020. Overall, sales were up 173 % year over year, reaching $ 140 million. Inari Medical achieved earnings of $ 0.43 per share, which is very good compared to many other emerging companies.
A unique feature of Inari Medical is that they offer an innovative product to treat cardiovascular diseases. In developed countries, as the population ages, the need for cardiovascular therapies will increase, especially those that can prevent death and improve the quality of one’s life.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Today’s share price for Inari Medical (NARI) is around $110.85. This means the Inari Medical’s value has soared 180.28% above its 52-week low. Shares of NARI have hit highs of $116.00 and lows of $107:15 in intraday trading. Over the past 52 weeks, shares of the company have reached a high of $127.42 and a low of $39.55, while recent trading sessions saw intraday changes of just -3.18%.